Claire Seal
0000-0002-6452-2516
1 paper found
Refreshing results…
A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance
Missing publications? Search for publications with a matching author name.